A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy

BACKGROUND: Nucleos(t)ide analogues reduce the incidence of hepatitis B virus (HBV) reactivation in cancer patients undergoing systemic cytotoxic chemotherapy but the experience of solid tumors remains limited. Aims. The aim of this study was to compare the efficacy of entecavir and lamivudine in th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Chen, Wen-Chi, Cheng, Jin-Shiung, Chiang, Po-Hung, Tsay, Feng-Woei, Chan, Hoi-Hung, Chang, Hsueh-Wen, Yu, Hsien-Chung, Tsai, Wei-Lun, Lai, Kwok-Hung, Hsu, Ping-I
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4488285/
https://ncbi.nlm.nih.gov/pubmed/26121480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0131545
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars